Compare McKesson Corporation (MCK) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs United Parcel Service Inc — how do they compare? McKesson Corporation trades at $825.15 (market cap $97.35B), while United Parcel Service Inc trades at $115.87 (market cap $96.18B). The key difference: McKesson Corporation and United Parcel Service Inc are close in size by market cap, and United Parcel Service Inc pays the higher dividend (5.8%). Which is the better fit depends on your goals.
| MCK | UPS | |
|---|---|---|
Market Cap | $97.35B | $96.18B |
Sector | Health | Industrials |
52-Week High | $995.69 | $120.00 |
52-Week Low | $659.01 | $82.58 |
Enterprise Value | $101.98B | $119.04B |
Dividend Yield | 0.39% | 5.8% |
Volume | — | 2,288,643 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
UPS stock trades at $112.97, down 4.03% today, with mixed technical signals showing bullish moving averages but overbought RSI levels. The company maintains strong profitability with 33.41% ROE and 5.94% net margin, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. Recent quarters show consistent earnings beats, with Q2 2026 results expected on July 28, 2026. Analyst sentiment is divided with 42% buy ratings and consensus price target of $112.
UPS faces near-term headwinds from revenue pressure and Amazon's logistics expansion, but cost-cutting initiatives and healthcare investments provide growth catalysts. The stock's current valuation at 19x P/E appears reasonable given strong cash flow generation. Key risks include competitive threats and economic sensitivity, while dividend sustainability remains a focus with the $1.64 per share payout.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
